These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 17227295

  • 21. Role of FK778 alone or in combination with tacrolimus or mTOR inhibitors as an immunomodulator of immunofunctions: in vitro evaluation of T cell proliferation and the expression of lymphocyte surface antigens.
    Millán O, Jiménez O, Fortuna V, Barceló JJ, Brunet M.
    Int J Immunopathol Pharmacol; 2006; 19(2):317-30. PubMed ID: 16831299
    [Abstract] [Full Text] [Related]

  • 22. Sirolimus vs mycophenolate moftile in Tacrolimus based therapy following induction with Antithymocyte globulin promotes regulatory T cell expansion and inhibits RORγt and T-bet expression in kidney transplantation.
    Jamali S, Sarafnejad A, Ahmadpoor P, Nafar M, Karimi M, Eteghadi A, Yekaninejad MS, Amirzargar AA.
    Hum Immunol; 2019 Sep; 80(9):739-747. PubMed ID: 30597187
    [Abstract] [Full Text] [Related]

  • 23. A clinical pharmacokinetic study of tacrolimus and sirolimus combination immunosuppression comparing simultaneous to separated administration.
    McAlister VC, Mahalati K, Peltekian KM, Fraser A, MacDonald AS.
    Ther Drug Monit; 2002 Jun; 24(3):346-50. PubMed ID: 12021624
    [Abstract] [Full Text] [Related]

  • 24. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
    Jiang H, Wynn C, Pan F, Ebbs A, Erickson LM, Kobayashi M.
    Transplantation; 2002 Jun 15; 73(11):1808-17. PubMed ID: 12085006
    [Abstract] [Full Text] [Related]

  • 25. Sensitivity of whole-blood T lymphocytes in individual patients to tacrolimus (FK 506): impact of interleukin-2 mRNA expression as surrogate measure of immunosuppressive effect.
    Härtel C, Schumacher N, Fricke L, Ebel B, Kirchner H, Müller-Steinhardt M.
    Clin Chem; 2004 Jan 15; 50(1):141-51. PubMed ID: 14709642
    [Abstract] [Full Text] [Related]

  • 26. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO, Ehlermann P, Koch A, Remppis A, Katus HA, Dengler TJ.
    Clin Ther; 2006 Jun 15; 28(6):893-905. PubMed ID: 16860172
    [Abstract] [Full Text] [Related]

  • 27. Application of allogeneic bone marrow cells in view of residual alloreactivity: sirolimus but not cyclosporine evolves tolerogenic properties.
    Timrott K, Vondran FW, Bektas H, Klempnauer J, Jäger MD.
    PLoS One; 2015 Jun 15; 10(3):e0119950. PubMed ID: 25836261
    [Abstract] [Full Text] [Related]

  • 28. Therapeutic drug monitoring of cyclosporine Neoral in de novo Chinese cardiac transplant recipients treated with an everolimus-cyclosporine immunosuppressive regimen.
    Wang CH, Chou NK, Wu FL, Ko WJ, Tsao CI, Chi NH, Hsu RB, Wang SS.
    Transplant Proc; 2006 Sep 15; 38(7):2132-4. PubMed ID: 16980022
    [Abstract] [Full Text] [Related]

  • 29. Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid.
    van Gelder T, Klupp J, Barten MJ, Christians U, Morris RE.
    Ther Drug Monit; 2001 Apr 15; 23(2):119-28. PubMed ID: 11294511
    [Abstract] [Full Text] [Related]

  • 30. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.
    Transpl Immunol; 2008 Nov 15; 20(1-2):32-42. PubMed ID: 18773960
    [Abstract] [Full Text] [Related]

  • 31. Preclinical results of sirolimus treatment in transplant models.
    Stepkowski SM.
    Transplant Proc; 2003 May 15; 35(3 Suppl):219S-226S. PubMed ID: 12742499
    [Abstract] [Full Text] [Related]

  • 32. Pharmacodynamic cyclosporine A-monitoring: relation of gene expression in lymphocytes to cyclosporine blood levels in cardiac allograft recipients.
    Konstandin MH, Sommerer C, Doesch A, Zeier M, Meuer SC, Katus HA, Dengler TJ, Giese T.
    Transpl Int; 2007 Dec 15; 20(12):1036-43. PubMed ID: 17850236
    [Abstract] [Full Text] [Related]

  • 33. New concepts in cyclosporine pharmacokinetic and dynamic monitoring: the impact of concomitant immunosuppression on target C2 concentrations.
    Brunet M, Millán O, Jiménez O, Campistol JM, Vidal E, Rojo I, Oppenheimer F, Fortuna V, Martorell J.
    Transplant Proc; 2004 Mar 15; 36(2 Suppl):437S-441S. PubMed ID: 15041382
    [Abstract] [Full Text] [Related]

  • 34. Cytokine mRNA expression in tolerant heart allografts after immunosuppression with cyclosporine, sirolimus or brequinar.
    Tian L, Stepkowski SM, Qu X, Wang ME, Wang M, Yu J, Kahan BD.
    Transpl Immunol; 1997 Sep 15; 5(3):189-98. PubMed ID: 9402685
    [Abstract] [Full Text] [Related]

  • 35. Quantitation of immunosuppression by tacrolimus using flow cytometric analysis of interleukin-2 and interferon-gamma inhibition in CD8(-) and CD8(+) peripheral blood T cells.
    Ahmed M, Venkataraman R, Logar AJ, Rao AS, Bartley GP, Robert K, Dodson FS, Shapiro R, Fung JJ, Zeevi A.
    Ther Drug Monit; 2001 Aug 15; 23(4):354-62. PubMed ID: 11477316
    [Abstract] [Full Text] [Related]

  • 36. Rapamycin antagonizes cyclosporin A- and tacrolimus (FK506)-mediated augmentation of linker for activation of T cell expression in T cells.
    Cho CS, Chang Z, Elkahwaji J, Scheunemann TL, Manthei ER, Colburn M, Knechtle SJ, Hamawy MM.
    Int Immunol; 2003 Nov 15; 15(11):1369-78. PubMed ID: 14565935
    [Abstract] [Full Text] [Related]

  • 37. The influence of immunosuppressive drugs on T- and B-cell apoptosis via p53-mediated pathway in vitro and in vivo.
    Boldt A, Barten MJ, Sagner A, Mohr FW, Adams V, Dhein S, Gummert JF.
    Transplantation; 2006 Aug 15; 82(3):422-7. PubMed ID: 16906043
    [Abstract] [Full Text] [Related]

  • 38. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
    Huang WH, Yan Y, De Boer B, Bishop GA, House AK.
    Transplantation; 2003 Feb 15; 75(3):368-74. PubMed ID: 12589161
    [Abstract] [Full Text] [Related]

  • 39. Pharmacodynamic monitoring of nuclear factor of activated T cell-regulated gene expression in liver allograft recipients on immunosuppressive therapy with calcineurin inhibitors in the course of time and correlation with acute rejection episodes--a prospective study.
    Steinebrunner N, Sandig C, Sommerer C, Hinz U, Giese T, Stremmel W, Zahn A.
    Ann Transplant; 2014 Jan 22; 19():32-40. PubMed ID: 24457606
    [Abstract] [Full Text] [Related]

  • 40. Effects of the pharmacokinetic interaction between orally administered sirolimus and cyclosporine on the synergistic prolongation of heart allograft survival in rats.
    Stepkowski SM, Napoli KL, Wang ME, Qu X, Chou TC, Kahan BD.
    Transplantation; 1996 Oct 15; 62(7):986-94. PubMed ID: 8878394
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.